Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
批准号:
10743327
负责人:
WEIGUO CUI
金额:
$40.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-11-18 至 2024-11-30
关键词:
ATAC-seqAcetylationAdoptive TransferAffectAntigensBindingBlocking AntibodiesCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell Differentiation processCellsChIP-seqChromatinChronicComputer AnalysisCytokine SignalingDevelopmentEffector CellEnhancersEpigenetic ProcessFlow CytometryGeneticGenetic TranscriptionGoalsHeterogeneityIndividualInfectionInflammatoryInterferonsInterleukin-10KnowledgeLymphocytic choriomeningitis virusMalignant NeoplasmsMediatingModelingMolecularNamesPD-1 blockadePathway interactionsPhenotypePopulationProcessRNA InterferenceResearchSignal TransductionSiteSolidSurfaceT cell differentiationT-LymphocyteT-Lymphocyte SubsetsTestingTherapeuticTimeViralViral PhysiologyVirusVirus Diseasesacute infectionantiviral immunitycancer immunotherapychronic infectioncytokinedesigneffector T cellexhaustexhaustionextracellulargene regulatory networkimprovedinsightinterleukin-21progenitorprogrammed cell death protein 1receptorresponseself-renewalsingle-cell RNA sequencingstem cellssuccesssynergism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
T cell exhaustion is a differentiation state that is marked by the loss of effector function and increased
expression of inhibitory receptors such as PD-1. Although virus-specific CD8 T cells are commonly considered
as a homogeneous population that gradually become exhausted over time, recent research has clearly
demonstrated that a CXCR5hi TCF-1hi subset is serving as a self-renewing progenitor population that can give
rise to a more terminally exhausted CXCR5lo TCF-1lo subset. To better dissect the heterogeneity of “exhausted”
CD8 T cells, the lab applied single cell RNA-seq (scRNA-seq) to the chronic LCMV infection and identified
three major subsets of virus-specific CD8 T cells that are phenotypically, functionally and transcriptionally
distinct. Not only had the lab validated the existence of these subsets of T cells experimentally by flow
cytometry, more advanced computational analyses were also performed to further predict their core
transcriptional networks and developmental trajectories. Collectively, the findings reveal that a TCF-1hi
progenitor subset can give rise to either a truly exhausted PD-1hi subset or a newly identified functional effector
population that is named CX3CR1hi subset. This discovery laid a solid framework that allows testing of how
extracellular signals and intrinsic genetic circuits regulate the formation and function of these three subsets of
CD8 T cells. More importantly, it provides unprecedented opportunities to explore the possibility of generating
more functional CX3CR1hi cells from TCF-1hi progenitors to overcome T cell exhaustion. This conceptual
breakthrough is obviously applicable to control over chronic viral infection as well as cancer. Intriguingly, the
preliminary study has also demonstrated that CD4 helper T cells, possibly through producing IL-21, are critical
for TCF-1hi CX3CR1hi transition. This led to the hypothesis that inflammatory cytokines (such as CD4-
derived IL-21) modulate the cellular, functional and transcriptional diversity of virus-specific CD8 T cells during
chronic LCMV infection. Blocking antibodies, RNA interference and genetic deletion models will be used to
further dissect how inflammatory cytokines and transcriptional networks regulate heterogeneity in T cell
exhaustion. Furthermore, the lab proposes to redirect CD8 T cell differentiation away from “exhaustion” by
providing additional “CD4 help”, either alone or in combination with PD-1 blockade. The lab will test if providing
IL-21 producing CD4 T cells through adoptive transfer could drive TCF-1hi progenitor cell differentiation into
functional CX3CR1hi effector cells. Overall, knowledge gained from this research will provide mechanistic
insights into how to redirect the formation of functional effector T cells and simultaneously limit T cell
exhaustion for improved viral control over chronic infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages
-
批准号:10209655
-
项目类别:
-
资助金额:$42.34万
-
财政年份:2021
-
负责人:WEIGUO CUI
-
依托单位:
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages
-
批准号:10591599
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2021
-
负责人:WEIGUO CUI
-
依托单位:
The cellular mechanisms of immunological memory development in COVID-19 patients
-
批准号:10745497
-
项目类别:
-
资助金额:$32.14万
-
财政年份:2021
-
负责人:WEIGUO CUI
-
依托单位:
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages
-
批准号:10372226
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2021
-
负责人:WEIGUO CUI
-
依托单位:
The cellular mechanisms of immunological memory development in COVID-19 patients
-
批准号:10465343
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2021
-
负责人:WEIGUO CUI
-
依托单位:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
-
批准号:10721409
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2019
-
负责人:WEIGUO CUI
-
依托单位:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
-
批准号:10536743
-
项目类别:
-
资助金额:$6.14万
-
财政年份:2019
-
负责人:WEIGUO CUI
-
依托单位:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
-
批准号:10428867
-
项目类别:
-
资助金额:$2.85万
-
财政年份:2019
-
负责人:WEIGUO CUI
-
依托单位:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
-
批准号:10311054
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2019
-
负责人:WEIGUO CUI
-
依托单位:
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic Viruses
-
批准号:9160163
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2016
-
负责人:WEIGUO CUI
-
依托单位:
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic Viruses
-
批准号:9274147
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2016
-
负责人:WEIGUO CUI
-
依托单位:
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic Viruses
-
批准号:9917687
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2016
-
负责人:WEIGUO CUI
-
依托单位:
海外基金